Relationship between thyroid function and ICU mortality: a prospective observation study
Open Access
- 1 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 16 (1), R11
- https://doi.org/10.1186/cc11151
Abstract
Although nonthyroidal illness syndrome is considered to be associated with adverse outcome in ICU patients, the performance of thyroid hormone levels in predicting clinical outcome in ICU patients is unimpressive. This study was conducted to assess the prognostic value of the complete thyroid indicators (free triiodothyronine (FT3), total triiodothyronine; free thyroxine, total thyroxine, thyroid-stimulating hormone and reverse triiodothyronine) in unselected ICU patients. A total of 480 consecutive patients without known thyroid diseases were screened for eligibility and followed up during their ICU stay. We collected each patient's baseline characteristics, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) score and thyroid hormone, N-terminal pro-brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) levels. The primary outcome was ICU mortality. Potential predictors were analyzed for possible association with outcomes. We also evaluated the ability of thyroid hormones together with APACHE II score to predict ICU mortality by calculation of net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices. Among the thyroid hormone indicators, FT3 had the greatest power to predict ICU mortality, as suggested by the largest area under the curve (AUC) of 0.762 ± 0.028. The AUC for FT3 level was less than that for APACHE II score (0.829 ± 0.022) but greater than that for NT-proBNP level (0.724 ± 0.030) or CRP level (0.689 ± 0.030). Multiple regression analysis revealed that FT3 level (standardized β = -0.600, P = 0.001), APACHE II score (standardized β = 0.912, P < 0.001), NT-proBNP level (standardized β = 0.459, P = 0.017) and CRP level (standardized β = 0.367, P = 0.030) could independently predict primary outcome. The addition of FT3 level to APACHE II score gave an NRI of 54.29% (P < 0.001) and an IDI of 36.54% (P < 0.001). The level of FT3 was significantly correlated with NT-proBNP levels (r = -0.344, P < 0.001) and CRP levels (r = -0.408, P < 0.001). In unselected ICU patients, FT3 was the most powerful and only independent predictor of ICU mortality among the complete indicators. The addition of FT3 level to the APACHE II score could significantly improve the ability to predict ICU mortality.Keywords
This publication has 43 references indexed in Scilit:
- IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsJCI Insight, 2011
- Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic reviewActa Endocrinologica, 2011
- Hormonal status in protracted critical illness and in-hospital mortalityCritical Care, 2011
- Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational studyCritical Care, 2011
- Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patientsActa Endocrinologica, 2009
- The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndromeBMC Endocrine Disorders, 2008
- The neuroendocrine response to stress is a dynamic processBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- A trial of thyroxine in acute renal failureKidney International, 2000
- Dangerous Dogmas in Medicine: The Nonthyroidal Illness SyndromeJournal of Clinical Endocrinology & Metabolism, 1999
- Relationship of admission thyroid function tests to outcome in critical illnessAnaesthesia, 1995